Belvedere Trading »

Tarsus Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $502k 14k 36.35

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding Tarsus Pharmaceuticals

Paradigm Biocapital Advisors
BlackRock
Morgan Stanley
Tang Capital Management
Cormorant Asset Management
Cowen And Company
Vanguard Group
Frazier Life Sciences Management
Jennison Associates
Perceptive Advisors
Ikarian Capital
Ensign Peak Advisors
Geode Capital Management
Artisan Partners Limited Partnership
Boone Capital Management

View all funds holding Tarsus Pharmaceuticals